Evidence map›Paper›PMID 27422517›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2016

Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond.

Elitsa A Ananieva, Jonathan D Powell, Susan M Hutson

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it, 184 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Leucine regulates the mTOR pathway to improve growth and enhance immune responses inAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Article
  9. Unravelling the pathogenesis and therapeutic approaches of pancreatic ductal adenocarcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Cell-nanoplastics association impacts cell proliferation and motility.bioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Elitsa A AnanievaDepartment of Biochemistry and Nutrition, Des Moines University, Des Moines, IA; elitsa.ananieva-stoyanova@dmu.edu.ORCID 0000-0003-3828-2093
Jonathan D PowellDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD; and.
Susan M HutsonDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA.
Des Moines University · USJohns Hopkins University · USVirginia Tech · US

Funding

EGR-2/3 and NAB2 in T Cell Anergy and ActivationR01CA098109 · NCI · JOHNS HOPKINS UNIVERSITY · PI POWELL, JONATHAN D · 2003 to 2013
$2.5M
NCI NIH HHS R01 CA098109
6 · The paper itself

Abstract

In connection with the increasing interest in metabolic regulation of the immune response, this review discusses current advances in understanding the role of leucine and leucine metabolism in T lymphocyte (T cell) activation. T cell activation during the development of an immune response depends on metabolic reprogramming to ensure that sufficient nutrients and energy are taken up by the highly proliferating T cells. Leucine has been described as an important essential amino acid and a nutrient signal that activates complex 1 of the mammalian target of rapamycin (mTORC1), which is a critical regulator of T cell proliferation, differentiation, and function. The role of leucine in these processes is further discussed in relation to amino acid transporters, leucine-degrading enzymes, and other metabolites of leucine metabolism. A new model of T cell regulation by leucine is proposed and outlines a chain of events that leads to the activation of mTORC1 in T cells.

Indexed as

AnimalsHumansImmunityImmunologic FactorsLeucineLymphocyte ActivationMechanistic Target of Rapamycin Complex 1Receptors, Antigen, T-CellSignal TransductionT-LymphocytesTransaminasesImmunologic FactorsLeucineMechanistic Target of Rapamycin Complex 1Receptors, Antigen, T-CellTransaminasesBCATcimmune functionKICleucinemTORC1T cells

Identifiers

PMID27422517
PMCPMC4942864
OpenAlexW2462837143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.